Search research articles
Contact Us
Filters
Showing results (111-120 of 136) with videos related to
Page
of 14
Sort By:
Journal of Psychopharmacology (Oxford, England)
|
September 1, 2016
Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences
Theresa M Carbonaro, Matthew P Bradstreet, Frederick S Barrett, et al.
Psychological Review
|
December 14, 2023
Unique effects of sedatives, dissociatives, psychedelics, stimulants, and cannabinoids on episodic memory: A review and reanalysis of acute drug effects on recollection, familiarity, and metamemory
Manoj K Doss, Jason Samaha, Frederick S Barrett, et al.
Frontiers in Neuroergonomics
|
January 18, 2024
Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [<sup>11</sup>C]MDL 100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation
Frederick S Barrett, Yun Zhou, Theresa M Carbonaro, et al.
Neuroimage
|
July 6, 2022
Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity
Andrew Gaddis, Daniel E Lidstone, Mary Beth Nebel, et al.
Journal of Addiction Medicine
|
August 24, 2010
Increased alcohol consumption, nonmedical prescription drug use, and illicit drug use are associated with energy drink consumption among college students
Amelia M Arria, Kimberly M Caldeira, Sarah J Kasperski, et al.
Psychiatry Research
|
July 31, 2023
Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis
Otto Simonsson, Per Carlbring, Robin Carhart-Harris, et al.
Journal of Psychoactive Drugs
|
July 14, 2023
Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences
Alan K Davis, Christopher Timmermann, Ana Maria Ortiz Bernal, et al.
Frontiers in Psychology
|
December 22, 2018
Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study
Joseph Barsuglia, Alan K Davis, Robert Palmer, et al.
Nature. Mental Health
|
April 13, 2026
Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer
Petros D Petridis, Jack Grinband, Gabrielle Agin-Liebes, et al.
Journal of Psychopharmacology (Oxford, England)
|
December 3, 2016
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R Griffiths, Matthew W Johnson, Michael A Carducci, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 136) with videos related to
Sort By:
Page
of 14
Journal of Psychopharmacology (Oxford, England)
|
September 1, 2016
Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences
Theresa M Carbonaro, Matthew P Bradstreet, Frederick S Barrett, et al.
Psychological Review
|
December 14, 2023
Unique effects of sedatives, dissociatives, psychedelics, stimulants, and cannabinoids on episodic memory: A review and reanalysis of acute drug effects on recollection, familiarity, and metamemory
Manoj K Doss, Jason Samaha, Frederick S Barrett, et al.
Frontiers in Neuroergonomics
|
January 18, 2024
Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [<sup>11</sup>C]MDL 100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation
Frederick S Barrett, Yun Zhou, Theresa M Carbonaro, et al.
Neuroimage
|
July 6, 2022
Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity
Andrew Gaddis, Daniel E Lidstone, Mary Beth Nebel, et al.
Journal of Addiction Medicine
|
August 24, 2010
Increased alcohol consumption, nonmedical prescription drug use, and illicit drug use are associated with energy drink consumption among college students
Amelia M Arria, Kimberly M Caldeira, Sarah J Kasperski, et al.
Psychiatry Research
|
July 31, 2023
Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis
Otto Simonsson, Per Carlbring, Robin Carhart-Harris, et al.
Journal of Psychoactive Drugs
|
July 14, 2023
Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences
Alan K Davis, Christopher Timmermann, Ana Maria Ortiz Bernal, et al.
Frontiers in Psychology
|
December 22, 2018
Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study
Joseph Barsuglia, Alan K Davis, Robert Palmer, et al.
Nature. Mental Health
|
April 13, 2026
Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer
Petros D Petridis, Jack Grinband, Gabrielle Agin-Liebes, et al.
Journal of Psychopharmacology (Oxford, England)
|
December 3, 2016
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R Griffiths, Matthew W Johnson, Michael A Carducci, et al.
Page
of 14